Funding for this research was provided by:
National Key Research and Development Program of China (2018YFE0114100)
Received: 25 May 2021
Accepted: 27 September 2021
First Online: 17 November 2021
: The trial was registered with Chinese Clinical Trial Registry (ChiCTR2100049376). This study was approved by two institutional review boards of Shandong Cancer Hospital and Institute and the First Affiliated Hospital of Shandong First Medical University. Written informed consent was obtained from all participants.
: Not applicable.
: The authors declare that they have no competing interests.